Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Shital Jibhe Article rating: 5.0

Overall volumes in futures & options currently stand at 3,90,04,211 contracts with a turnover of Rs.26,55,699.80 crore.

Index trend and stocks in action June 28, 2019
Index trend and stocks in action June 28, 2019

Index trend and stocks in action June 28, 2019

DSIJ Intelligence-3 Article rating: 5.0

The level of 20-DMA (11,851) should be closely watched by the traders. Only a sustainable move above the 20-DMA is likely to take the Nifty towards the 12,000 mark, while on the downside, the level of 11,800, followed by 11,740, is likely to act as support. Stocks for news: Infosys, Cox & Kings, Excel Industries, MMTC, Lupin.

Axis Bank turns volatile as it mulls over share sale
Axis Bank turns volatile as it mulls over share sale

Axis Bank turns volatile as it mulls over share sale

DSIJ Intelligence Article rating: 5.0

The shares of Axis Bank sank more than 2 per cent from the day’s high of Rs. 806.65 during Thursday’s trading session. This could be because the bank is mulling over raising funds to the tune of at least US$1.3 billion by means of a share sale to institutional investors.

Lupin gets tentative USFDA approval for Mirabegron tablet
Lupin gets tentative USFDA approval for Mirabegron tablet

Lupin gets tentative USFDA approval for Mirabegron tablet

DSIJ Intelligence Article rating: 5.0

Lupin Limited (Lupin) on Thursday announced that it has received tentative approval from United States Food and Drug Administration (USFDA) for its Mirabegron Extended Release (ER) Tablets, 25 mg and 50 mg.

Spice Jet launches non-stop flight to Hong Kong
Spice Jet launches non-stop flight to Hong Kong

Spice Jet launches non-stop flight to Hong Kong

DSIJ Intelligence Article rating: 3.5

SpiceJet has launched daily non-stop flights connecting India’s financial capital, Mumbai with Hong Kong. The shares of SpiceJet closed 4 per cent lower after its intraday gain of 1.5 per cent.

Sun Pharma, Chinese firm CMS to develop eye, arthritis drug
Sun Pharma, Chinese firm CMS to develop eye, arthritis drug

Sun Pharma, Chinese firm CMS to develop eye, arthritis drug

DSIJ Intelligence Article rating: 5.0

Sun Pharmaceutical Industries Limited has entered into an exclusive licensing agreement with a subsidiary of Chinese pharma major China Medical System Holdings (CMS) to develop and commercialise Cyclosporine A 0.09 per cent eye drops and Tildrakizumab a medication for psoriasis and psoriatic arthritis in Greater China.

L&T wins twin orders from ONGC
L&T wins twin orders from ONGC

L&T wins twin orders from ONGC

Pratik Shastri Article rating: 5.0

The hydrocarbon engineering division of L&T has been awarded twin orders from ONGC. The company has categorised the order as large order, which mean the order value is between Rs. 2,000 to Rs. 5,000 crore.

RSS
First33613362336333643366336833693370Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR